Evidence map›Paper›PMID 19193866›Full record

ArticleAmerican journal of physiology. Cell physiology2009

Fibrinogen-induced endothelin-1 production from endothelial cells.

Utpal Sen, Neetu Tyagi, Phani K Patibandla, William L Dean, Suresh C Tyagi, Andrew M Roberts, David Lominadze

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. The Effect of Extreme Cold on Complete Blood Count and Biochemical Indicators: A Case Study.International journal of environmental research and public health · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Role of TLR4 signaling in the nephrotoxicity of heme and heme proteins.American journal of physiology. Renal physiology · 2018
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Utpal SenDept. of Physiology, Univ. of Louisville, School of Medicine, Bldg. A, Rm. 1115, 500 South Preston St., Louisville, KY 40202, USA.
Neetu Tyagi
Phani K Patibandla
William L Dean
Suresh C Tyagi
Andrew M Roberts
David Lominadze
University of Louisville · US

Funding

Mechanism of Vascular Remodeling in HyperhomocysteinemiaR01HL071010 · NHLBI · UNIVERSITY OF MISSISSIPPI MEDICAL CENTER · PI TYAGI, SURESH C. · 2002 to 2010
$2.7M
Fibronogen-Induced Vasconstriction during HypertensionR01HL080394 · NHLBI · UNIVERSITY OF LOUISVILLE · PI LOMINADZE, DAVID · 2007 to 2011
$2.1M
NHLBI NIH HHS HL-71010NHLBI NIH HHS HL-80394NHLBI NIH HHS R01 HL080394NINDS NIH HHS NS-051568
6 · The paper itself

Abstract

We previously demonstrated that fibrinogen (Fg) binding to the vascular endothelial intercellular adhesion molecule-1 (ICAM-1) leads to microvascular constriction in vivo and in vitro. Although a role of endothelin-1 (ET-1) in this Fg-induced vasoconstriction was suggested, the mechanism of action was not clear. In the current study, we tested the hypothesis that Fg-induced vasoconstriction results from ET-1 production by vascular endothelial cells (EC) and is mediated by activation of extracellular signal-regulated kinase -1/2 (ERK-1/2). Confluent, rat heart microvascular endothelial cells (RHMECs) were treated with one of the following: Fg (2 or 4 mg/ml), Fg (4 mg/ml) with ERK-1/2 kinase inhibitors (PD-98059 or U-0126), Fg (4 mg/ml) with an antibody against ICAM-1, or medium alone for 45 min. The amount of ET-1 formed and the concentration of released von Willebrand factor (vWF) in the cell culture medium were measured by ELISAs. Fg-induced exocytosis of Weibel-Palade bodies (WPBs) was assessed by immunocytochemistry. Phosphorylation of ERK-1/2 was detected by Western blot analysis. Fg caused a dose-dependent increase in ET-1 formation and release of vWF from the RHMECs. This Fg-induced increase in ET-1 production was inhibited by specific ERK-1/2 kinase inhibitors and by anti-ICAM-1 antibody. Immunocytochemical staining showed that an increase in Fg concentration enhanced exocytosis of WPBs in ECs. A specific endothelin type B receptor blocker, BQ-788, attenuated the enhanced phosphorylation of ERK-1/2 in ECs caused by increased Fg content in the culture medium. The presence of an endothelin converting enzyme inhibitor, SM-19712, slightly decreased Fg-induced phosphorylation of ERK-1/2, but inhibited production of Fg-induced ET-1 production. These results suggest that Fg-induced vasoconstriction may be mediated, in part, by activation of ERK-1/2 signaling and increased production of ET-1 that further increases EC ERK-1/2 signaling. Thus, an increased content of Fg may enhance vasoconstriction through increased production of ET-1.

Indexed as

AnimalsAspartic Acid EndopeptidasesButadienesCells, CulturedCoronary VesselsEndothelial CellsEndothelin-1Endothelin B Receptor AntagonistsEndothelin-Converting EnzymesExocytosisFibrinogenFlavonoidsHumansIntercellular Adhesion Molecule-1MetalloendopeptidasesMicrovessels2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-oneAspartic Acid EndopeptidasesBQ 788ButadienesEndothelin-1Endothelin B Receptor AntagonistsEndothelin-Converting EnzymesFibrinogenFlavonoidsIntercellular Adhesion Molecule-1MetalloendopeptidasesMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3NitrilesOligopeptidesPiperidinesProtein Kinase InhibitorsReceptor, Endothelin BSM 19712SulfonamidesSulfonylurea CompoundsU 0126von Willebrand Factor

Identifiers

PMID19193866
PMCPMC2670653
OpenAlexW2082863785

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.